Our Leadership Team
Octave’s team consists of highly experienced healthcare founders, high-level investors and first-in-class collaborators.
Entrepreneur. Visionary. Passionate.
Bill has more than 25 years of start-up experience in a broad range of medical specialties intersecting science, technology, clinical medicine, and business strategy. Prior to founding Octave Bioscience, he served as the CEO of Crescendo Bioscience which created novel measurement tools and software in the field of rheumatology. Prior to this, he was the President of Alpha BioPartners, a strategic consulting firm advising the launch of new life sciences companies. While at Alpha BioPartners, Bill created the business plan for Crescendo and co-founded Altheus Therapeutics and Biolytx Pharmaceuticals. Prior to that, he served as the initial CEO of Selexys Pharmaceuticals and interim CEO of Inoveon in ophthalmology. In the 1990s, Bill was Chairman and CEO of UroCor, a urology specialty diagnostics company which he scaled from start-up through IPO. Earlier in his career, he was Vice President of Baxter International’s $1.0 billion Scientific Products Division and held management positions at the American Hospital Supply and Becton Dickinson. He currently serves on the board of directors for CareDx, Navican, Genalyte and CoFactor. Previously he was on the board of Prometheus Laboratories. Bill holds a BS in Business Management from Bob Jones University.
Leader. Builder. Problem Solver.
Melinda has over two decades of experience starting and leading health companies. Using her expertise, she wraps a company around a technical/scientific team so they can focus on meeting the company’s milestones. Melinda built CardioDx, a molecular diagnostics company specializing in cardiovascular genomics, and ParAllele, a high-throughput sequencing and SNP discovery company from the foundation point. ParAllele was acquired by Affymetrix in what one investor said was their best investment of the decade. Previously, she served as the Inaugural Entrepreneur in Residence for New York City, solving problems for aspiring entrepreneurs, and as Chair of the Board for the Save the Redwoods League. Prior to ParAllele, she guided Molecular Dynamics Manufacturing, building it from an 8 person to 85 person manufacturing organization. Melinda holds an MBA from Harvard and a BS from UC Berkeley.
Innovator. Data driven. Purposeful.
Erwan has over two decades experience in both start-ups and global corporations across multiple industries: high tech, industrials, and digital health. Prior to Octave Bioscience, he was global head of software engineering for the medical device group at EMD Serono, in Switzerland, integrating health in people’s digital life for the chronic diseases, growth hormones, and consumer divisions. Prior to this, he led a 300 engineers research and development team for building control systems at Honeywell, developing global digital IoT platforms for home automation and commercial buildings. Prior to that, he led teams at high tech start-ups, Cisco and Logitech. Erwan credits his time at Cisco as being the most formative for developing his leadership, strategic and program skills. He led a firewall release with projected revenues of $1.5B, delivered on time and within budget. Erwan holds a Global Executive MBA from TRIUM, a joint degree between NYU Stern, London
School of Economics and HEC Paris. He also holds a Master of Science in Mechanical
Engineering (Diplome d’Ingenieur) from Sup’Meca, Saint-Ouen, France.